These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 21633102

  • 1. Proliferative glomerulonephritis with monoclonal IgG deposits secondary to chronic lymphocytic leukemia. Report of two cases.
    Barbour SJ, Beaulieu MC, Zalunardo NY, Magil AB.
    Nephrol Dial Transplant; 2011 Aug; 26(8):2712-4. PubMed ID: 21633102
    [Abstract] [Full Text] [Related]

  • 2. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
    Robak T, Lech-Maranda E, Robak P.
    Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
    [Abstract] [Full Text] [Related]

  • 3. Successful treatment with bortezomib and dexamethasone for proliferative glomerulonephritis with monoclonal IgG deposits in multiple myeloma: a case report.
    Noto R, Kamiura N, Ono Y, Tabata S, Hara S, Yokoi H, Yoshimoto A, Yanagita M.
    BMC Nephrol; 2017 Apr 06; 18(1):127. PubMed ID: 28385149
    [Abstract] [Full Text] [Related]

  • 4. Membranoproliferative glomerulonephritis and light-chain nephropathy in association with chronic lymphocytic leukemia.
    Mutluay R, Aki SZ, Erten Y, Konca C, Yagci M, Barit G, Sindel S.
    Clin Nephrol; 2008 Dec 06; 70(6):527-31. PubMed ID: 19049712
    [Abstract] [Full Text] [Related]

  • 5. Patterns of noncryoglobulinemic glomerulonephritis with monoclonal Ig deposits: correlation with IgG subclass and response to rituximab.
    Guiard E, Karras A, Plaisier E, Duong Van Huyen JP, Fakhouri F, Rougier JP, Noel LH, Callard P, Delahousse M, Ronco P.
    Clin J Am Soc Nephrol; 2011 Jul 06; 6(7):1609-16. PubMed ID: 21700823
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Low-dose fludarabine and cyclophosphamide in elderly patients with B-cell chronic lymphocytic leukemia refractory to conventional therapy.
    Marotta G, Bigazzi C, Lenoci M, Tozzi M, Bocchia M, Lauria F.
    Haematologica; 2000 Dec 06; 85(12):1268-70. PubMed ID: 11114133
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prolonged progression-free survival in patients with chronic lymphocytic leukemia receiving granulocyte colony-stimulating factor during treatment with fludarabine, cyclophosphamide, and rituximab.
    Gruber M, Fleiss K, Porpaczy E, Skrabs C, Hauswirth AW, Gaiger A, Vanura K, Heintel D, Shehata M, Einberger C, Thalhammer R, Fonatsch C, Jäger U.
    Ann Hematol; 2011 Oct 06; 90(10):1131-6. PubMed ID: 21617923
    [Abstract] [Full Text] [Related]

  • 11. Renal failure secondary to leukemic infiltration of kidneys in CLL--a case report and review of literature.
    Uprety D, Peterson A, Shah BK.
    Ann Hematol; 2013 Jan 06; 92(2):271-3. PubMed ID: 22875063
    [No Abstract] [Full Text] [Related]

  • 12. [Successful combined treatment with rituximab and high dose immunoglobulin in a patient with chronic lymphocytic leukemia with fludarabine-induced severe immune thrombocytopenia].
    Telek B, Batár P, Uvardy M.
    Orv Hetil; 2005 Aug 21; 146(34):1791-3. PubMed ID: 16184881
    [Abstract] [Full Text] [Related]

  • 13. Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia.
    Keating MJ, O'Brien S, Albitar M, Lerner S, Plunkett W, Giles F, Andreeff M, Cortes J, Faderl S, Thomas D, Koller C, Wierda W, Detry MA, Lynn A, Kantarjian H.
    J Clin Oncol; 2005 Jun 20; 23(18):4079-88. PubMed ID: 15767648
    [Abstract] [Full Text] [Related]

  • 14. [Specific palatal infiltration in B-cell chronic lymphocytic leukemia].
    Cervigón I, Palomo A, Torres-Iglesias LM, Solano F, Zapata AM.
    Actas Dermosifiliogr; 2011 May 20; 102(4):305-7. PubMed ID: 21354544
    [No Abstract] [Full Text] [Related]

  • 15. Simultaneous clinical resolution of focal segmental glomerulosclerosis associated with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab.
    Arampatzis S, Giannakoulas N, Liakopoulos V, Eleftheriadis T, Kourti P, Karasavvidou F, Matsouka P, Stefanidis I.
    BMC Nephrol; 2011 Jul 05; 12():33. PubMed ID: 21729272
    [Abstract] [Full Text] [Related]

  • 16. Fludarabine, cyclophosphamide, and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non-Hodgkin lymphoma.
    Tam CS, Wolf M, Prince HM, Januszewicz EH, Westerman D, Lin KI, Carney D, Seymour JF.
    Cancer; 2006 Jun 01; 106(11):2412-20. PubMed ID: 16649223
    [Abstract] [Full Text] [Related]

  • 17. Population pharmacokinetics of rituximab in patients with chronic lymphocytic leukemia.
    Li J, Zhi J, Wenger M, Valente N, Dmoszynska A, Robak T, Mangat R, Joshi A, Visich J.
    J Clin Pharmacol; 2012 Dec 01; 52(12):1918-26. PubMed ID: 22235140
    [Abstract] [Full Text] [Related]

  • 18. Paraneoplastic pemphigus despite treatment with rituximab, fludarabine and cyclophosphamide in chronic lymphocytic leukemia.
    Schierl M, Foedinger D, Geissler K, Rappersberger K, Feldmann R.
    Eur J Dermatol; 2008 Dec 01; 18(6):717-8. PubMed ID: 19049939
    [No Abstract] [Full Text] [Related]

  • 19. Clinical efficacy of immunochemotherapy with fludarabine, epirubicin and rituximab in the treatment for chronic lymphocytic leukaemia and prolymphocytic leukaemia.
    Chow KU, Kim SZ, von Neuhoff N, Schlegelberger B, Stilgenbauer S, Wunderle L, Cordes HJ, Bergmann L.
    Eur J Haematol; 2011 Nov 01; 87(5):426-33. PubMed ID: 21749447
    [Abstract] [Full Text] [Related]

  • 20. [Rapidly progressive proliferative glomerulonephritis with monoclonal immunoglobulin G deposits despite the mild histological changes. Case report].
    Bajcsi D, Constantinou K, Krenács L, Barabás Z, Molnár S, Nyiraty S, Ábrahám G, Iványi B.
    Orv Hetil; 2018 Sep 01; 159(38):1567-1572. PubMed ID: 30227733
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.